Tekla Healthcare Investors Paid Distribution

Rhea-AI Summary

On January 6, 2021, Tekla Healthcare Investors announced a special cash distribution of $0.05 per share, primarily sourced from net realized long-term capital gains. This distribution reflects a total aggregate of net unrealized appreciation of portfolio securities and net realized gains exceeding $319 million. Distributions for the fiscal year to date total $0.53 per share. The Fund, which focuses on the healthcare sector, is managed by Tekla Capital Management, with approximately $3.3 billion in assets under management as of December 31, 2020.

Positive

• Special cash distribution of $0.05 per share indicates strong performance.
• Total cumulative distributions for the fiscal year to date is $0.53 per share.

Negative

• None.

On January 6, 2021, Tekla Healthcare Investors paid a special cash distribution of $0.05 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $319,723,166, of which $309,953,241 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on January 6, 2021, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. All amounts are expressed per common share.

	Current Distribution	Percentage Breakdown of Current Distribution	Total Cumulative Distributions for the Fiscal Year to Date1	Percentage Breakdown of the Total Cumulative Distributions for the Fiscal Year to Date1
Net Investment Income	$0.0000	0%	$0.0000	0%
Net Realized ST Cap Gains	$0.0000	0%	$0.4380	83%
Net Realized LT Cap Gains	$0.0500	100%	$0.0920	17%
Return of Capital or Other Capital Source	$0.0000	0%	$0.0000	0%
TOTAL (per common share):	$0.0500	100%	$0.5300	100%

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from November 30, 2015 through November 30, 2020	4.77%
Annualized current distribution rate expressed as a percentage of NAV as of November 30, 20203	0.20%
Cumulative total return at NAV for the fiscal year, through November 30, 20202	4.41%
Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of November 30, 20201	2.16%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Tekla Healthcare Investors (NYSE: HQH) is a closed-end fund that invests in companies in the healthcare industry.

Tekla Capital Management LLC, the Fund’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $3.3 billion of assets under management as of December 31, 2020. Tekla also serves as investment adviser to Tekla Life Sciences Investors (NYSE: HQL), Tekla Healthcare Opportunities Fund (NYSE: THQ) and Tekla World Healthcare Fund (NYSE: THW), closed-end funds that invest in companies in the healthcare and life sciences industries. Information regarding the Funds and Tekla Capital Management LLC can be found at www.teklacap.com.

Please contact Destra Capital Advisors, the Fund’s marketing and investor support services agent, at HQH@destracapital.com or call (877) 855-3434 if you have any questions regarding HQH.

1 The Fund’s current fiscal year began on October 1, 2020.
2 Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2020 through November 30, 2020.
3 This distribution represents a one time payment to satisfy annual tax distribution requirements and therefore has not been annualized for the period.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005747/en/

FAQ

What is the recent distribution amount for Tekla Healthcare Investors (HQH)?

Tekla Healthcare Investors (HQH) announced a distribution of $0.05 per share on January 6, 2021.

What sources funded the recent distribution for HQH?

The recent distribution primarily derived from net realized long-term capital gains.

How much did Tekla Healthcare Investors distribute this fiscal year to date?

The total cumulative distributions for the fiscal year to date amount to $0.53 per share.

What is the aggregate net appreciation of Tekla Healthcare Investors' portfolio?

The aggregate net unrealized appreciation of portfolio securities and net realized gains is estimated at $319,723,166.

Who manages Tekla Healthcare Investors (HQH) and what is their AUM?

Tekla Healthcare Investors is managed by Tekla Capital Management, which has approximately $3.3 billion in assets under management.